Related Experiment Video

Updated: Oct 20, 2026

Isolation and Analysis of Brain-sequestered Leukocytes from Plasmodium berghei ANKA-infected Mice
12:48

Isolation and Analysis of Brain-sequestered Leukocytes from Plasmodium berghei ANKA-infected Mice

Published on: January 2, 2013

12.9K

Pathogenesis of Cerebral Malaria: New Trends and Insights for Developing Adjunctive Therapies

Praveen Kishore Sahu1,2, Sanjib Mohanty1,2

  • 1Department of Molecular Biology & Infectious Diseases, Community Welfare Society Hospital, Rourkela 769042, Odisha, India.

Pathogens (Basel, Switzerland)
|April 28, 2023
PubMed

Insights

Cerebral malaria (CM) lacks specific treatments. Recent research using advanced methods is revealing key factors driving CM, paving the way for targeted therapies.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Background:

  • Cerebral malaria (CM), a severe manifestation of Plasmodium falciparum infection, currently has no specific or adjunctive treatments.
  • The complex pathogenesis of CM is driven by virulence factors, immune responses, and patient-specific variables like age and parasite factors, making it difficult to understand.

Purpose of the Study:

  • To explore recent advancements in understanding the key determinants of cerebral malaria.
  • To identify potential avenues for developing targeted adjunctive therapies for CM.

Main Methods:

  • Review of molecular, immunologic, and advanced neuroradiologic studies.
  • Application of machine-learning approaches to analyze CM data.

Main Results:

  • New insights into the complex pathogenetic mechanisms of CM have been uncovered.
  • Identification of key determinants influencing CM variations in patients.

Conclusions:

  • Emerging research provides a foundation for designing novel, specific adjunctive therapies for cerebral malaria.
  • Future therapies may be tailored to individual patient and parasite variations rather than a one-size-fits-all approach.
Keywords:
Plasmodium falciparumadjunctive therapiesbrain swellingcerebral malariapathogenesis

More Related Videos

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging09:04

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging

Published on: June 8, 2017

6.6K
Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases09:13

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Published on: November 22, 2024

1.4K

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...